Synergy Pharmaceuticals, Inc. SGYP was a big mover last session with its shares rising over 6% on the day. The move came on solid volume with far more shares changing hands on Thursday than in a normal session. This reverses the recent downtrend of the company as the stock has lost roughly 23% since March 14.
This biopharmaceutical company has seen 2 positive estimate revisions in the last 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if Thursday’s jump can turn into more strength down the road.
Synergy Pharmaceuticals currently has a Zacks Rank #2 (Buy) and its Earnings ESP is 0.00%.
Investors interested in the Med-Drugs industry may also consider Alcobra Ltd. ADHD. The stock carries a Zacks Rank #1 (Strong Buy).
Is SGYP going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment